Net Income (Loss) Attributable to Parent in USD of Telesis Bio Inc. from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Telesis Bio Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q1 2020 to Q3 2024.
  • Telesis Bio Inc. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2024 was -$6.64M, a 37.5% increase year-over-year.
  • Telesis Bio Inc. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2024 was -$45.6M, a 19.3% decline year-over-year.
  • Telesis Bio Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$47.7M, a 1.54% increase from 2022.
  • Telesis Bio Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$48.5M, a 24.4% decline from 2021.
  • Telesis Bio Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$39M, a 116% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Telesis Bio Inc. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$45.6M -$6.64M +$3.99M +37.5% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 -$49.5M -$12.6M -$4.3M -51.9% 01 Apr 2024 30 Jun 2024 10-Q 07 Nov 2024
Q1 2024 -$45.2M -$8.64M +$2.48M +22.3% 01 Jan 2024 31 Mar 2024 10-Q 07 Nov 2024
Q4 2023 -$47.7M -$17.7M -$9.56M -117% 01 Oct 2023 31 Dec 2023 10-K 29 Mar 2024
Q3 2023 -$38.2M -$10.6M +$1.68M +13.7% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$39.9M -$8.29M +$6.54M +44.1% 01 Apr 2023 30 Jun 2023 10-Q 07 Nov 2024
Q1 2023 -$46.4M -$11.1M +$2.08M +15.7% 01 Jan 2023 31 Mar 2023 10-Q 07 Nov 2024
Q4 2022 -$48.5M -$8.13M +$4.36M +34.9% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 -$52.8M -$12.3M -$2.49M -25.3% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$50.3M -$14.8M -$5.63M -61.2% 01 Apr 2022 30 Jun 2022 10-Q 13 Nov 2023
Q1 2022 -$44.7M -$13.2M -$5.75M -77.3% 01 Jan 2022 31 Mar 2022 10-Q 13 Nov 2023
Q4 2021 -$39M -$12.5M -$6.91M -124% 01 Oct 2021 31 Dec 2021 10-K 22 Mar 2023
Q3 2021 -$32.1M -$9.82M -$5.36M -120% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 -$26.7M -$9.2M -$5.12M -125% 01 Apr 2021 30 Jun 2021 10-Q 09 Nov 2022
Q1 2021 -$21.6M -$7.44M -$3.56M -91.8% 01 Jan 2021 31 Mar 2021 10-Q 09 Nov 2022
Q4 2020 -$18M -$5.58M 01 Oct 2020 31 Dec 2020 10-K 23 Mar 2022
Q3 2020 -$4.47M 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$4.08M 01 Apr 2020 30 Jun 2020 10-Q 10 Nov 2021
Q1 2020 -$3.88M 01 Jan 2020 31 Mar 2020 10-Q 10 Nov 2021

Telesis Bio Inc. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$47.7M +$747K +1.54% 01 Jan 2023 31 Dec 2023 10-K 29 Mar 2024
2022 -$48.5M -$9.51M -24.4% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 -$39M -$20.9M -116% 01 Jan 2021 31 Dec 2021 10-K 22 Mar 2023
2020 -$18M 01 Jan 2020 31 Dec 2020 10-K 23 Mar 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.